ACROSS ONCOLOGY. WORLDWIDE

Josep Tabernero

ESMO President

ESMO SUMMIT MIDDLE EAST

Friday, 6th April 2018

ESMO

ESMO IN A NUTSHELL

Europe’s leading Medical Oncology Society

ESMO is the leading European professional organisation for

medical oncology, working across Europe and around the world to

erase boundaries in cancer care and to provide medical oncology

education within an integrated approach to cancer care

ESMO MISSIONImprove the quality

of prevention, diagnosis, treatment,

supportive and palliative care

Disseminate knowledge in

oncology to cancer patients and the public

Facilitate equal access to optimal cancer care for all

cancer patients

Maintain liaisons with other oncology

specialties, cancer leagues, universities,

patient groups & where appropriate, the

pharmaceutical industry

Advance the art, science, recognition,

and practice of oncology

Promote education in oncology to ensure a

high standard of qualification for medical oncologists within the multidisciplinary team

Educate and train persons involved in clinical cancer care

and research

ESMO 2020 VISION

Securing the best possible outcomes for people with cancer

Membership

ConferencesPublic Policy

Career Development

OncologyProClinical Practice

ESMO MEMBERSHIP AND GLOBAL NETWORK

Membership Distribution

North America

9%

South America 6%

Europe 55%

Africa 5%

Asia-Pacific 25%

As of 31 December 2017

> 18,000 members

Over 150 countries

Reciprocal membership agreements

with 50 national oncology societies

TOOLS AND RESOURCES

OncologyPRO – ESMO’s online education portal

Scientific and educational online portal

Direct access 24/7 to

oncology news, scientific and educational resources

Information by disease-type

Continuously updated

DISSEMINATING CANCER INFORMATION WORLDWIDE

The official journal of ESMO, providing rapid and efficient peer-review publications on innovative cancer treatments, or translational

work related to oncology and precision medicine.

Ranked #10 in Oncology

Over 4.3 million downloads in 2016

Accessed by 3,569 institutions worldwide

Over 2 million unique readers in 188 countries

Over 15,000 followers on Twitter

Official journal of JSMO

ESMO’s online-only, peer-reviewed open access journal, dedicated to publishing high-quality medical research and educational content from all

disciplines of oncology.

Indexing: Google Scholar, PubMed Central, Emerging Sources Citation Index (Web of Science)

Global reach: 241 submissions from 34 countries

Broad coverage: 157 papers published

Affiliations with AIOM, CSCO, KACO, JSMO

SETTING THE STANDARDS OF CARE FOR

CLINICAL CANCER PRACTICE

ESMO Clinical Practice Guidelines

Evidence-based

guidelines to support

clinicians in delivering

patients the best cancer treatment options

Latest information on

diagnostic criteria, disease

staging, risk assessment,

treatment plan and follow-up

Regularly updated and reviewed by

leading oncology experts

More than 70 available from

the ESMO website or the ESMO mobile

app

Approximately 20 patient

friendly versions available

ESMO MEETINGSExchange expertise and knowledge at our first class events

Congresses Symposia Educational Courses

ENSURING ACCESS TO CANCER MEDICINES

A critical issue for medical oncologists

To treat patients according to the ESMO Clinical

Practice Guidelines, medical oncologists need to have

access to the cancer medicines recommended in

the guidelines.

In Europe ESMO works closely with the European Medicines Agency and the

European Network of Health Technology Assessment in

order to harmonise the approval and reimbursement

process for cancer medicines in Europe.

ESMO has conducted international surveys on the

availability of cancer medicines and has proposed recommendations on how to

reduce the barriers.

ESMO keeps its members updated on the latest in personalised medicine, immunotherapies and biosimilars in a rapidly-

advancing landscape of new cancer treatments

ESMO: MEDICAL ONCOLOGY EDUCATION BROUGHT

DIRECTLY TO YOU

A global society with a tailored education offer to meet your local needs

ESMO SUMMIT MIDDLE EAST 2018

Dubai, United Arab Emirates - 06 Apr - 07 Apr 2018

Oncology Updates: From Evidence to Practice

Designed to address the specific challenges faced by oncology professionals practising in this region

Local and international experts covering the cancer types most frequently encountered in Sub-Saharan Africa

Series of clinical case presentations followed by time for discussion

To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO annualcongress

To review the current standard of care for key malignancies from a local and international perspective

To discuss the current controversies in the management of specific cancers

Participants Category

Faculty 32

Delegates 263

ESMO Staff 3

Total 298

ESMO SUMMIT MIDDLE EAST 2018

Participants Overview

UAE 55%

Iraq 18%

Lebanon 7,3%

Saudi Arabia 4,7%

ESMO SUMMIT MIDDLE EAST 2018

Country break down (Delegates: 250+) Country DelegateAustralia 1Canada 1Czech Republic 1China 3Egypt 6France 1Germany 1Hungary 1India 1Iran 3Iraq 42Jordan 6Korea 1Saudi Arabia 12Kuwait 2Lebanon 17Netherlands 1Philippines 6Syria 1UAE 156Total 263